NCT00004181 Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia Status COMPLETED Phase PHASE2
NCT00004179 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00004175 Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer Status COMPLETED Phase PHASE2
NCT00004174 Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00004172 Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00004171 Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00004169 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease Status COMPLETED Phase PHASE2
NCT00004145 Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00004135 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00004132 Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00004128 Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia Status UNKNOWN Phase PHASE3
NCT00004125 Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes Status COMPLETED Phase PHASE3
NCT00004114 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer Status WITHDRAWN Phase PHASE1
NCT00004112 Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00004092 Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer Status COMPLETED Phase PHASE2
NCT00004088 Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00004067 Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 Status COMPLETED Phase PHASE3
NCT00004061 Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00004039 Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma Status WITHDRAWN Phase PHASE2
NCT00004036 Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer Status UNKNOWN Phase PHASE1